https://www.selleckchem.com/products/tak-875.html
CONCLUSION This study identified that an amantadine-plus-cerebrolysin regimen additively affects patients with prolonged disorders of consciousness. A future controlled trial is needed to investigate the efficacy of each regimen in patients with prolonged disorders of consciousness secondary to acquired brain injury, particularly for patients who have remained in a prolonged vegetative state after acquired brain injury.The spreading hypothesis of neurodegeneration assumes an expansion of neural pathologies along existing neural pathways
Like
Comment
Share
